Global Platinum based Cancer Drug Market Size, Status and Forecast 2020-2026
Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Platinum based Cancer Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Platinum based Cancer Drug industry.
Based on our recent survey, we have several different scenarios about the Platinum based Cancer Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1392.2 million in 2019. The market size of Platinum based Cancer Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platinum based Cancer Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platinum based Cancer Drug market in terms of revenue.
Players, stakeholders, and other participants in the global Platinum based Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Platinum based Cancer Drug market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Platinum based Cancer Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platinum based Cancer Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platinum based Cancer Drug market.
The following players are covered in this report:
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin in 2017 is about 71%, and the proportion is in decreasing trend from 2013 to 2017.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Platinum based Cancer Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Platinum based Cancer Drug industry.
Based on our recent survey, we have several different scenarios about the Platinum based Cancer Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 1392.2 million in 2019. The market size of Platinum based Cancer Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Platinum based Cancer Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Platinum based Cancer Drug market in terms of revenue.
Players, stakeholders, and other participants in the global Platinum based Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Platinum based Cancer Drug market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Platinum based Cancer Drug market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Platinum based Cancer Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Platinum based Cancer Drug market.
The following players are covered in this report:
- Sanofi
- Hengrui Medicine
- ASK Pharma
- Yi Bai Pharmaceutical
- Qilu Pharmaceutical
- Teva
- Pfizer
- Dr Reddy's Laboratories
- Mylan
- Sun Pharma
- Novartis
- Debiopharm
- Accord Healthcare
- SK Chemicals
- Cisplatin
- Oxaliplatin
- Carboplatin
- Other
- Colorectal Cancer
- Ovarian Cancer
- Lung Cancer
- Other
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Platinum based Cancer Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cisplatin
1.4.3 Oxaliplatin
1.4.4 Carboplatin
1.4.5 Other
1.5 Market by Application
1.5.1 Global Platinum based Cancer Drug Market Share by Application: 2020 VS 2026
1.5.2 Colorectal Cancer
1.5.3 Ovarian Cancer
1.5.4 Lung Cancer
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Platinum based Cancer Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Platinum based Cancer Drug Industry
1.6.1.1 Platinum based Cancer Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Platinum based Cancer Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Platinum based Cancer Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Platinum based Cancer Drug Market Perspective (2015-2026)
2.2 Platinum based Cancer Drug Growth Trends by Regions
2.2.1 Platinum based Cancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Platinum based Cancer Drug Historic Market Share by Regions (2015-2020)
2.2.3 Platinum based Cancer Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Platinum based Cancer Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Platinum based Cancer Drug Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Platinum based Cancer Drug Players by Market Size
3.1.1 Global Top Platinum based Cancer Drug Players by Revenue (2015-2020)
3.1.2 Global Platinum based Cancer Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Platinum based Cancer Drug Market Concentration Ratio
3.2.1 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Platinum based Cancer Drug Revenue in 2019
3.3 Platinum based Cancer Drug Key Players Head office and Area Served
3.4 Key Players Platinum based Cancer Drug Product Solution and Service
3.5 Date of Enter into Platinum based Cancer Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Platinum based Cancer Drug Historic Market Size by Type (2015-2020)
4.2 Global Platinum based Cancer Drug Forecasted Market Size by Type (2021-2026)
5 PLATINUM BASED CANCER DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Platinum based Cancer Drug Market Size by Application (2015-2020)
5.2 Global Platinum based Cancer Drug Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Platinum based Cancer Drug Market Size (2015-2020)
6.2 Platinum based Cancer Drug Key Players in North America (2019-2020)
6.3 North America Platinum based Cancer Drug Market Size by Type (2015-2020)
6.4 North America Platinum based Cancer Drug Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Platinum based Cancer Drug Market Size (2015-2020)
7.2 Platinum based Cancer Drug Key Players in Europe (2019-2020)
7.3 Europe Platinum based Cancer Drug Market Size by Type (2015-2020)
7.4 Europe Platinum based Cancer Drug Market Size by Application (2015-2020)
8 CHINA
8.1 China Platinum based Cancer Drug Market Size (2015-2020)
8.2 Platinum based Cancer Drug Key Players in China (2019-2020)
8.3 China Platinum based Cancer Drug Market Size by Type (2015-2020)
8.4 China Platinum based Cancer Drug Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Platinum based Cancer Drug Market Size (2015-2020)
9.2 Platinum based Cancer Drug Key Players in Japan (2019-2020)
9.3 Japan Platinum based Cancer Drug Market Size by Type (2015-2020)
9.4 Japan Platinum based Cancer Drug Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Platinum based Cancer Drug Market Size (2015-2020)
10.2 Platinum based Cancer Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Platinum based Cancer Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Platinum based Cancer Drug Market Size by Application (2015-2020)
11 INDIA
11.1 India Platinum based Cancer Drug Market Size (2015-2020)
11.2 Platinum based Cancer Drug Key Players in India (2019-2020)
11.3 India Platinum based Cancer Drug Market Size by Type (2015-2020)
11.4 India Platinum based Cancer Drug Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Platinum based Cancer Drug Market Size (2015-2020)
12.2 Platinum based Cancer Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Platinum based Cancer Drug Market Size by Type (2015-2020)
12.4 Central & South America Platinum based Cancer Drug Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview and Its Total Revenue
13.1.3 Sanofi Platinum based Cancer Drug Introduction
13.1.4 Sanofi Revenue in Platinum based Cancer Drug Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Hengrui Medicine
13.2.1 Hengrui Medicine Company Details
13.2.2 Hengrui Medicine Business Overview and Its Total Revenue
13.2.3 Hengrui Medicine Platinum based Cancer Drug Introduction
13.2.4 Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2015-2020)
13.2.5 Hengrui Medicine Recent Development
13.3 ASK Pharma
13.3.1 ASK Pharma Company Details
13.3.2 ASK Pharma Business Overview and Its Total Revenue
13.3.3 ASK Pharma Platinum based Cancer Drug Introduction
13.3.4 ASK Pharma Revenue in Platinum based Cancer Drug Business (2015-2020)
13.3.5 ASK Pharma Recent Development
13.4 Yi Bai Pharmaceutical
13.4.1 Yi Bai Pharmaceutical Company Details
13.4.2 Yi Bai Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Introduction
13.4.4 Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020)
13.4.5 Yi Bai Pharmaceutical Recent Development
13.5 Qilu Pharmaceutical
13.5.1 Qilu Pharmaceutical Company Details
13.5.2 Qilu Pharmaceutical Business Overview and Its Total Revenue
13.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Introduction
13.5.4 Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020)
13.5.5 Qilu Pharmaceutical Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview and Its Total Revenue
13.6.3 Teva Platinum based Cancer Drug Introduction
13.6.4 Teva Revenue in Platinum based Cancer Drug Business (2015-2020)
13.6.5 Teva Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer Platinum based Cancer Drug Introduction
13.7.4 Pfizer Revenue in Platinum based Cancer Drug Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Dr Reddy's Laboratories
13.8.1 Dr Reddy's Laboratories Company Details
13.8.2 Dr Reddy's Laboratories Business Overview and Its Total Revenue
13.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Introduction
13.8.4 Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2015-2020)
13.8.5 Dr Reddy's Laboratories Recent Development
13.9 Mylan
13.9.1 Mylan Company Details
13.9.2 Mylan Business Overview and Its Total Revenue
13.9.3 Mylan Platinum based Cancer Drug Introduction
13.9.4 Mylan Revenue in Platinum based Cancer Drug Business (2015-2020)
13.9.5 Mylan Recent Development
13.10 Sun Pharma
13.10.1 Sun Pharma Company Details
13.10.2 Sun Pharma Business Overview and Its Total Revenue
13.10.3 Sun Pharma Platinum based Cancer Drug Introduction
13.10.4 Sun Pharma Revenue in Platinum based Cancer Drug Business (2015-2020)
13.10.5 Sun Pharma Recent Development
13.11 Novartis
10.11.1 Novartis Company Details
10.11.2 Novartis Business Overview and Its Total Revenue
10.11.3 Novartis Platinum based Cancer Drug Introduction
10.11.4 Novartis Revenue in Platinum based Cancer Drug Business (2015-2020)
10.11.5 Novartis Recent Development
13.12 Debiopharm
10.12.1 Debiopharm Company Details
10.12.2 Debiopharm Business Overview and Its Total Revenue
10.12.3 Debiopharm Platinum based Cancer Drug Introduction
10.12.4 Debiopharm Revenue in Platinum based Cancer Drug Business (2015-2020)
10.12.5 Debiopharm Recent Development
13.13 Accord Healthcare
10.13.1 Accord Healthcare Company Details
10.13.2 Accord Healthcare Business Overview and Its Total Revenue
10.13.3 Accord Healthcare Platinum based Cancer Drug Introduction
10.13.4 Accord Healthcare Revenue in Platinum based Cancer Drug Business (2015-2020)
10.13.5 Accord Healthcare Recent Development
13.14 SK Chemicals
10.14.1 SK Chemicals Company Details
10.14.2 SK Chemicals Business Overview and Its Total Revenue
10.14.3 SK Chemicals Platinum based Cancer Drug Introduction
10.14.4 SK Chemicals Revenue in Platinum based Cancer Drug Business (2015-2020)
10.14.5 SK Chemicals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Platinum based Cancer Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Platinum based Cancer Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cisplatin
1.4.3 Oxaliplatin
1.4.4 Carboplatin
1.4.5 Other
1.5 Market by Application
1.5.1 Global Platinum based Cancer Drug Market Share by Application: 2020 VS 2026
1.5.2 Colorectal Cancer
1.5.3 Ovarian Cancer
1.5.4 Lung Cancer
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): Platinum based Cancer Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Platinum based Cancer Drug Industry
1.6.1.1 Platinum based Cancer Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Platinum based Cancer Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Platinum based Cancer Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Platinum based Cancer Drug Market Perspective (2015-2026)
2.2 Platinum based Cancer Drug Growth Trends by Regions
2.2.1 Platinum based Cancer Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Platinum based Cancer Drug Historic Market Share by Regions (2015-2020)
2.2.3 Platinum based Cancer Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Platinum based Cancer Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Platinum based Cancer Drug Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Platinum based Cancer Drug Players by Market Size
3.1.1 Global Top Platinum based Cancer Drug Players by Revenue (2015-2020)
3.1.2 Global Platinum based Cancer Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Platinum based Cancer Drug Market Concentration Ratio
3.2.1 Global Platinum based Cancer Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Platinum based Cancer Drug Revenue in 2019
3.3 Platinum based Cancer Drug Key Players Head office and Area Served
3.4 Key Players Platinum based Cancer Drug Product Solution and Service
3.5 Date of Enter into Platinum based Cancer Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Platinum based Cancer Drug Historic Market Size by Type (2015-2020)
4.2 Global Platinum based Cancer Drug Forecasted Market Size by Type (2021-2026)
5 PLATINUM BASED CANCER DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Platinum based Cancer Drug Market Size by Application (2015-2020)
5.2 Global Platinum based Cancer Drug Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Platinum based Cancer Drug Market Size (2015-2020)
6.2 Platinum based Cancer Drug Key Players in North America (2019-2020)
6.3 North America Platinum based Cancer Drug Market Size by Type (2015-2020)
6.4 North America Platinum based Cancer Drug Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Platinum based Cancer Drug Market Size (2015-2020)
7.2 Platinum based Cancer Drug Key Players in Europe (2019-2020)
7.3 Europe Platinum based Cancer Drug Market Size by Type (2015-2020)
7.4 Europe Platinum based Cancer Drug Market Size by Application (2015-2020)
8 CHINA
8.1 China Platinum based Cancer Drug Market Size (2015-2020)
8.2 Platinum based Cancer Drug Key Players in China (2019-2020)
8.3 China Platinum based Cancer Drug Market Size by Type (2015-2020)
8.4 China Platinum based Cancer Drug Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Platinum based Cancer Drug Market Size (2015-2020)
9.2 Platinum based Cancer Drug Key Players in Japan (2019-2020)
9.3 Japan Platinum based Cancer Drug Market Size by Type (2015-2020)
9.4 Japan Platinum based Cancer Drug Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Platinum based Cancer Drug Market Size (2015-2020)
10.2 Platinum based Cancer Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Platinum based Cancer Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Platinum based Cancer Drug Market Size by Application (2015-2020)
11 INDIA
11.1 India Platinum based Cancer Drug Market Size (2015-2020)
11.2 Platinum based Cancer Drug Key Players in India (2019-2020)
11.3 India Platinum based Cancer Drug Market Size by Type (2015-2020)
11.4 India Platinum based Cancer Drug Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Platinum based Cancer Drug Market Size (2015-2020)
12.2 Platinum based Cancer Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Platinum based Cancer Drug Market Size by Type (2015-2020)
12.4 Central & South America Platinum based Cancer Drug Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview and Its Total Revenue
13.1.3 Sanofi Platinum based Cancer Drug Introduction
13.1.4 Sanofi Revenue in Platinum based Cancer Drug Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Hengrui Medicine
13.2.1 Hengrui Medicine Company Details
13.2.2 Hengrui Medicine Business Overview and Its Total Revenue
13.2.3 Hengrui Medicine Platinum based Cancer Drug Introduction
13.2.4 Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2015-2020)
13.2.5 Hengrui Medicine Recent Development
13.3 ASK Pharma
13.3.1 ASK Pharma Company Details
13.3.2 ASK Pharma Business Overview and Its Total Revenue
13.3.3 ASK Pharma Platinum based Cancer Drug Introduction
13.3.4 ASK Pharma Revenue in Platinum based Cancer Drug Business (2015-2020)
13.3.5 ASK Pharma Recent Development
13.4 Yi Bai Pharmaceutical
13.4.1 Yi Bai Pharmaceutical Company Details
13.4.2 Yi Bai Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Introduction
13.4.4 Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020)
13.4.5 Yi Bai Pharmaceutical Recent Development
13.5 Qilu Pharmaceutical
13.5.1 Qilu Pharmaceutical Company Details
13.5.2 Qilu Pharmaceutical Business Overview and Its Total Revenue
13.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Introduction
13.5.4 Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020)
13.5.5 Qilu Pharmaceutical Recent Development
13.6 Teva
13.6.1 Teva Company Details
13.6.2 Teva Business Overview and Its Total Revenue
13.6.3 Teva Platinum based Cancer Drug Introduction
13.6.4 Teva Revenue in Platinum based Cancer Drug Business (2015-2020)
13.6.5 Teva Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer Platinum based Cancer Drug Introduction
13.7.4 Pfizer Revenue in Platinum based Cancer Drug Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Dr Reddy's Laboratories
13.8.1 Dr Reddy's Laboratories Company Details
13.8.2 Dr Reddy's Laboratories Business Overview and Its Total Revenue
13.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Introduction
13.8.4 Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2015-2020)
13.8.5 Dr Reddy's Laboratories Recent Development
13.9 Mylan
13.9.1 Mylan Company Details
13.9.2 Mylan Business Overview and Its Total Revenue
13.9.3 Mylan Platinum based Cancer Drug Introduction
13.9.4 Mylan Revenue in Platinum based Cancer Drug Business (2015-2020)
13.9.5 Mylan Recent Development
13.10 Sun Pharma
13.10.1 Sun Pharma Company Details
13.10.2 Sun Pharma Business Overview and Its Total Revenue
13.10.3 Sun Pharma Platinum based Cancer Drug Introduction
13.10.4 Sun Pharma Revenue in Platinum based Cancer Drug Business (2015-2020)
13.10.5 Sun Pharma Recent Development
13.11 Novartis
10.11.1 Novartis Company Details
10.11.2 Novartis Business Overview and Its Total Revenue
10.11.3 Novartis Platinum based Cancer Drug Introduction
10.11.4 Novartis Revenue in Platinum based Cancer Drug Business (2015-2020)
10.11.5 Novartis Recent Development
13.12 Debiopharm
10.12.1 Debiopharm Company Details
10.12.2 Debiopharm Business Overview and Its Total Revenue
10.12.3 Debiopharm Platinum based Cancer Drug Introduction
10.12.4 Debiopharm Revenue in Platinum based Cancer Drug Business (2015-2020)
10.12.5 Debiopharm Recent Development
13.13 Accord Healthcare
10.13.1 Accord Healthcare Company Details
10.13.2 Accord Healthcare Business Overview and Its Total Revenue
10.13.3 Accord Healthcare Platinum based Cancer Drug Introduction
10.13.4 Accord Healthcare Revenue in Platinum based Cancer Drug Business (2015-2020)
10.13.5 Accord Healthcare Recent Development
13.14 SK Chemicals
10.14.1 SK Chemicals Company Details
10.14.2 SK Chemicals Business Overview and Its Total Revenue
10.14.3 SK Chemicals Platinum based Cancer Drug Introduction
10.14.4 SK Chemicals Revenue in Platinum based Cancer Drug Business (2015-2020)
10.14.5 SK Chemicals Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Platinum based Cancer Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Platinum based Cancer Drug Revenue
Table 3. Ranking of Global Top Platinum based Cancer Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cisplatin
Table 6. Key Players of Oxaliplatin
Table 7. Key Players of Carboplatin
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Platinum based Cancer Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Platinum based Cancer Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Platinum based Cancer Drug Players to Combat Covid-19 Impact
Table 14. Global Platinum based Cancer Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Platinum based Cancer Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Platinum based Cancer Drug Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Platinum based Cancer Drug Market Share by Regions (2015-2020)
Table 18. Global Platinum based Cancer Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Platinum based Cancer Drug Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Platinum based Cancer Drug Market Growth Strategy
Table 24. Main Points Interviewed from Key Platinum based Cancer Drug Players
Table 25. Global Platinum based Cancer Drug Revenue by Players (2015-2020) (Million US$)
Table 26. Global Platinum based Cancer Drug Market Share by Players (2015-2020)
Table 27. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2019)
Table 28. Global Platinum based Cancer Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Platinum based Cancer Drug Product Solution and Service
Table 31. Date of Enter into Platinum based Cancer Drug Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 34. Global Platinum based Cancer Drug Market Size Share by Type (2015-2020)
Table 35. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2026)
Table 36. Global Platinum based Cancer Drug Market Size Share by Application (2015-2020)
Table 37. Global Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 38. Global Platinum based Cancer Drug Market Size Share by Application (2021-2026)
Table 39. North America Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 41. North America Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 42. North America Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 43. North America Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 44. North America Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 45. Europe Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 47. Europe Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 49. Europe Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 51. China Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 52. China Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 53. China Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 54. China Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 55. China Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 56. China Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 57. Japan Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 59. Japan Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 61. Japan Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 65. Southeast Asia Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 67. Southeast Asia Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 69. India Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 70. India Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 71. India Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 72. India Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 73. India Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 74. India Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 77. Central & South America Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 79. Central & South America Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Product
Table 84. Sanofi Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 85. Sanofi Recent Development
Table 86. Hengrui Medicine Company Details
Table 87. Hengrui Medicine Business Overview
Table 88. Hengrui Medicine Product
Table 89. Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 90. Hengrui Medicine Recent Development
Table 91. ASK Pharma Company Details
Table 92. ASK Pharma Business Overview
Table 93. ASK Pharma Product
Table 94. ASK Pharma Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 95. ASK Pharma Recent Development
Table 96. Yi Bai Pharmaceutical Company Details
Table 97. Yi Bai Pharmaceutical Business Overview
Table 98. Yi Bai Pharmaceutical Product
Table 99. Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 100. Yi Bai Pharmaceutical Recent Development
Table 101. Qilu Pharmaceutical Company Details
Table 102. Qilu Pharmaceutical Business Overview
Table 103. Qilu Pharmaceutical Product
Table 104. Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 105. Qilu Pharmaceutical Recent Development
Table 106. Teva Company Details
Table 107. Teva Business Overview
Table 108. Teva Product
Table 109. Teva Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 110. Teva Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Product
Table 114. Pfizer Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 115. Pfizer Recent Development
Table 116. Dr Reddy's Laboratories Business Overview
Table 117. Dr Reddy's Laboratories Product
Table 118. Dr Reddy's Laboratories Company Details
Table 119. Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 120. Dr Reddy's Laboratories Recent Development
Table 121. Mylan Company Details
Table 122. Mylan Business Overview
Table 123. Mylan Product
Table 124. Mylan Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 125. Mylan Recent Development
Table 126. Sun Pharma Company Details
Table 127. Sun Pharma Business Overview
Table 128. Sun Pharma Product
Table 129. Sun Pharma Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 130. Sun Pharma Recent Development
Table 131. Novartis Company Details
Table 132. Novartis Business Overview
Table 133. Novartis Product
Table 134. Novartis Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 135. Novartis Recent Development
Table 136. Debiopharm Company Details
Table 137. Debiopharm Business Overview
Table 138. Debiopharm Product
Table 139. Debiopharm Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 140. Debiopharm Recent Development
Table 141. Accord Healthcare Company Details
Table 142. Accord Healthcare Business Overview
Table 143. Accord Healthcare Product
Table 144. Accord Healthcare Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 145. Accord Healthcare Recent Development
Table 146. SK Chemicals Company Details
Table 147. SK Chemicals Business Overview
Table 148. SK Chemicals Product
Table 149. SK Chemicals Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 150. SK Chemicals Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 1. Platinum based Cancer Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Platinum based Cancer Drug Revenue
Table 3. Ranking of Global Top Platinum based Cancer Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Platinum based Cancer Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cisplatin
Table 6. Key Players of Oxaliplatin
Table 7. Key Players of Carboplatin
Table 8. Key Players of Other
Table 9. COVID-19 Impact Global Market: (Four Platinum based Cancer Drug Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Platinum based Cancer Drug Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Platinum based Cancer Drug Players to Combat Covid-19 Impact
Table 14. Global Platinum based Cancer Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Platinum based Cancer Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Platinum based Cancer Drug Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Platinum based Cancer Drug Market Share by Regions (2015-2020)
Table 18. Global Platinum based Cancer Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Platinum based Cancer Drug Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Platinum based Cancer Drug Market Growth Strategy
Table 24. Main Points Interviewed from Key Platinum based Cancer Drug Players
Table 25. Global Platinum based Cancer Drug Revenue by Players (2015-2020) (Million US$)
Table 26. Global Platinum based Cancer Drug Market Share by Players (2015-2020)
Table 27. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2019)
Table 28. Global Platinum based Cancer Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Platinum based Cancer Drug Product Solution and Service
Table 31. Date of Enter into Platinum based Cancer Drug Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 34. Global Platinum based Cancer Drug Market Size Share by Type (2015-2020)
Table 35. Global Platinum based Cancer Drug Revenue Market Share by Type (2021-2026)
Table 36. Global Platinum based Cancer Drug Market Size Share by Application (2015-2020)
Table 37. Global Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 38. Global Platinum based Cancer Drug Market Size Share by Application (2021-2026)
Table 39. North America Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 41. North America Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 42. North America Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 43. North America Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 44. North America Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 45. Europe Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 47. Europe Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 49. Europe Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 51. China Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 52. China Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 53. China Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 54. China Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 55. China Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 56. China Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 57. Japan Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 59. Japan Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 61. Japan Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 65. Southeast Asia Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 67. Southeast Asia Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 69. India Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 70. India Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 71. India Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 72. India Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 73. India Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 74. India Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Platinum based Cancer Drug Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Platinum based Cancer Drug Market Share (2019-2020)
Table 77. Central & South America Platinum based Cancer Drug Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Platinum based Cancer Drug Market Share by Type (2015-2020)
Table 79. Central & South America Platinum based Cancer Drug Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Platinum based Cancer Drug Market Share by Application (2015-2020)
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Product
Table 84. Sanofi Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 85. Sanofi Recent Development
Table 86. Hengrui Medicine Company Details
Table 87. Hengrui Medicine Business Overview
Table 88. Hengrui Medicine Product
Table 89. Hengrui Medicine Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 90. Hengrui Medicine Recent Development
Table 91. ASK Pharma Company Details
Table 92. ASK Pharma Business Overview
Table 93. ASK Pharma Product
Table 94. ASK Pharma Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 95. ASK Pharma Recent Development
Table 96. Yi Bai Pharmaceutical Company Details
Table 97. Yi Bai Pharmaceutical Business Overview
Table 98. Yi Bai Pharmaceutical Product
Table 99. Yi Bai Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 100. Yi Bai Pharmaceutical Recent Development
Table 101. Qilu Pharmaceutical Company Details
Table 102. Qilu Pharmaceutical Business Overview
Table 103. Qilu Pharmaceutical Product
Table 104. Qilu Pharmaceutical Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 105. Qilu Pharmaceutical Recent Development
Table 106. Teva Company Details
Table 107. Teva Business Overview
Table 108. Teva Product
Table 109. Teva Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 110. Teva Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Product
Table 114. Pfizer Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 115. Pfizer Recent Development
Table 116. Dr Reddy's Laboratories Business Overview
Table 117. Dr Reddy's Laboratories Product
Table 118. Dr Reddy's Laboratories Company Details
Table 119. Dr Reddy's Laboratories Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 120. Dr Reddy's Laboratories Recent Development
Table 121. Mylan Company Details
Table 122. Mylan Business Overview
Table 123. Mylan Product
Table 124. Mylan Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 125. Mylan Recent Development
Table 126. Sun Pharma Company Details
Table 127. Sun Pharma Business Overview
Table 128. Sun Pharma Product
Table 129. Sun Pharma Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 130. Sun Pharma Recent Development
Table 131. Novartis Company Details
Table 132. Novartis Business Overview
Table 133. Novartis Product
Table 134. Novartis Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 135. Novartis Recent Development
Table 136. Debiopharm Company Details
Table 137. Debiopharm Business Overview
Table 138. Debiopharm Product
Table 139. Debiopharm Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 140. Debiopharm Recent Development
Table 141. Accord Healthcare Company Details
Table 142. Accord Healthcare Business Overview
Table 143. Accord Healthcare Product
Table 144. Accord Healthcare Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 145. Accord Healthcare Recent Development
Table 146. SK Chemicals Company Details
Table 147. SK Chemicals Business Overview
Table 148. SK Chemicals Product
Table 149. SK Chemicals Revenue in Platinum based Cancer Drug Business (2015-2020) (Million US$)
Table 150. SK Chemicals Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Platinum based Cancer Drug Market Share by Type: 2020 VS 2026
Figure 2. Cisplatin Features
Figure 3. Oxaliplatin Features
Figure 4. Carboplatin Features
Figure 5. Other Features
Figure 6. Global Platinum based Cancer Drug Market Share by Application: 2020 VS 2026
Figure 7. Colorectal Cancer Case Studies
Figure 8. Ovarian Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Platinum based Cancer Drug Report Years Considered
Figure 12. Global Platinum based Cancer Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Platinum based Cancer Drug Market Share by Regions: 2020 VS 2026
Figure 14. Global Platinum based Cancer Drug Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Platinum based Cancer Drug Market Share by Players in 2019
Figure 17. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Platinum based Cancer Drug Revenue in 2019
Figure 19. North America Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 28. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Hengrui Medicine Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 30. ASK Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. ASK Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 32. Yi Bai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Yi Bai Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 34. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Qilu Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 36. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Teva Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pfizer Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 40. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Dr Reddy's Laboratories Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 42. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Mylan Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 44. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sun Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 46. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Novartis Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 48. Debiopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Debiopharm Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 50. Accord Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Accord Healthcare Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 52. SK Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. SK Chemicals Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Figure 1. Global Platinum based Cancer Drug Market Share by Type: 2020 VS 2026
Figure 2. Cisplatin Features
Figure 3. Oxaliplatin Features
Figure 4. Carboplatin Features
Figure 5. Other Features
Figure 6. Global Platinum based Cancer Drug Market Share by Application: 2020 VS 2026
Figure 7. Colorectal Cancer Case Studies
Figure 8. Ovarian Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Platinum based Cancer Drug Report Years Considered
Figure 12. Global Platinum based Cancer Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Platinum based Cancer Drug Market Share by Regions: 2020 VS 2026
Figure 14. Global Platinum based Cancer Drug Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Platinum based Cancer Drug Market Share by Players in 2019
Figure 17. Global Top Platinum based Cancer Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Platinum based Cancer Drug as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Platinum based Cancer Drug Revenue in 2019
Figure 19. North America Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Platinum based Cancer Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Sanofi Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 28. Hengrui Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Hengrui Medicine Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 30. ASK Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. ASK Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 32. Yi Bai Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Yi Bai Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 34. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Qilu Pharmaceutical Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 36. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Teva Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pfizer Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 40. Dr Reddy's Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Dr Reddy's Laboratories Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 42. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Mylan Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 44. Sun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Sun Pharma Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 46. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Novartis Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 48. Debiopharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Debiopharm Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 50. Accord Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Accord Healthcare Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 52. SK Chemicals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. SK Chemicals Revenue Growth Rate in Platinum based Cancer Drug Business (2015-2020)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
